Fraum, Tyler J. http://orcid.org/0000-0001-6573-5081
Cannella, Roberto
Ludwig, Daniel R.
Tsai, Richard
Naeem, Muhammad
LeBlanc, Maverick
Salter, Amber
Tsung, Allan
Shetty, Anup S.
Borhani, Amir A.
Furlan, Alessandro
Fowler, Kathryn J.
Article History
Received: 1 July 2019
Revised: 12 August 2019
Accepted: 10 September 2019
First Online: 25 October 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Fraum.
: The authors declare that they have no conflict of interest.
: One of the authors (Dr. Salter) has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: In a study previously published in <i>Abdominal Radiology</i>, we reported on the 48 cHCC-CCAs and 25 iCCAs from the at-risk cohort in the current study. Additionally, we have a manuscript accepted (currently in press) by <i>HPB</i> that includes 20 of 44 cHCC-CCAs and 84 of 148 iCCAs from the not at-risk cohort in the current study. Importantly, both this previously published study and the in press manuscript focus on the diagnostic accuracy of LI-RADS v2018 for differentiating HCCs from non-HCC malignancies. In contrast, the current manuscript focuses exclusively on the non-HCC malignancies and addresses a completely different question (specifically, whether there are significant differences in the imaging appearances non-HCC PLCs in the at-risk versus not at-risk cohorts).
: • Retrospective• Diagnostic or prognostic study• Multicenter study